The correlations between SPARE-BA3 and Alzheimer’s disease-related clinical, molecular and genetic variables were consistently reduced and non-significant for the latter two, compared with SPARE-BA1 or SPARE-BA2. Here, CD9 is linked to early-onset autosomal dominant Alzheimer disease.